Skip to main content

BNTX · BioNTech SE · Share Buybacks

Track BNTX — free
$86.00 +0.40 (+0.47%) Play latest call Q3 2026 earnings call transcript
Market Cap
$21.22B
Shares
247.93M
Volume · Nov 16 510.65K Avg daily vol (3M) 1.23M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$1,000,000,000
as of 2026-09-30 · from Press release (reviewed)· through 2027-05-06
Remaining Authorization
$536,700,000
as of 2026-09-30 · from Press release (reviewed)
Program Utilization
46.3% $463,300,000 used of $1,000,000,000
Program Announced Authorized Remaining Runs Through
— $1,000,000,000 $536,700,000 2027-05-06
Key facts CIK 1776985 CUSIP 09075V102 13F (30d) 239 filings 212 filers Visit website Investor relations